These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 33506898)
1. LINC00641 regulates prostate cancer cell growth and apoptosis via the miR-365a-3p/VGLL4 axis. Liu WH; Lu JJ; Yu RK; Zhou L; Yu Q; Li DF; Zhu QH Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):108-115. PubMed ID: 33506898 [TBL] [Abstract][Full Text] [Related]
2. LINC00641 regulates autophagy and intervertebral disc degeneration by acting as a competitive endogenous RNA of miR-153-3p under nutrition deprivation stress. Wang XB; Wang H; Long HQ; Li DY; Zheng X J Cell Physiol; 2019 May; 234(5):7115-7127. PubMed ID: 30378116 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA LINC00641 promotes cell growth and migration through modulating miR-378a/ZBTB20 axis in acute myeloid leukemia. Wang J; Liu ZH; Yu LJ Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7498-7509. PubMed ID: 31539138 [TBL] [Abstract][Full Text] [Related]
4. LncRNA HOXA11-AS promotes cell growth by sponging miR-24-3p to regulate JPT1 in prostate cancer. Cheng Y; Xiong HY; Li YM; Zuo HR; Liu Y; Liao GL Eur Rev Med Pharmacol Sci; 2021 Jul; 25(14):4668-4677. PubMed ID: 34337714 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA LINC00173 serves as sponge for miR-338-3p to promote prostate cancer progression via regulating Rab25. Hu CH; Yang XJ; Yu L; Wang LY; Zhao XC; Han CH Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9290-9302. PubMed ID: 33015770 [TBL] [Abstract][Full Text] [Related]
6. LINC00641 hinders the progression of cervical cancer by targeting miR-378a-3p/CPEB3. Zhang Y; Yu R; Li L J Gene Med; 2020 Sep; 22(9):e3212. PubMed ID: 32367630 [TBL] [Abstract][Full Text] [Related]
7. LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade. Li Z; Hong S; Liu Z Biochem Biophys Res Commun; 2018 Sep; 503(3):1825-1829. PubMed ID: 30060954 [TBL] [Abstract][Full Text] [Related]
8. The lncRNA MEG3/miR-16-5p/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells. Tao Y; Yue P; Miao Y; Gao S; Wang B; Leng SX; Meng X; Zhang H J Gene Med; 2021 Feb; 23(2):e3291. PubMed ID: 33141998 [TBL] [Abstract][Full Text] [Related]
9. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis. Xiao S; Song B Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis. Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4. Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037 [TBL] [Abstract][Full Text] [Related]
12. Long intergenic noncoding RNA 00641 inhibits breast cancer cell proliferation, migration, and invasion by sponging miR-194-5p. Mao Q; Lv M; Li L; Sun Y; Liu S; Shen Y; Liu Z; Luo S J Cell Physiol; 2020 Mar; 235(3):2668-2675. PubMed ID: 31490021 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of LncRNA SNHG7 inhibited epithelial-mesenchymal transition in prostate cancer though miR-324-3p/WNT2B axis in vitro. Han Y; Hu H; Zhou J Pathol Res Pract; 2019 Oct; 215(10):152537. PubMed ID: 31324390 [TBL] [Abstract][Full Text] [Related]
14. lncRNA OGFRP1 functions as a ceRNA to promote the progression of prostate cancer by regulating SARM1 level via miR-124-3p. Yan K; Hou L; Liu T; Jiao W; Ma Q; Fang Z; Zhang S; Song D; Liu J; Gao X; Fan Y Aging (Albany NY); 2020 May; 12(10):8880-8892. PubMed ID: 32428870 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA SNHG14 promotes malignancy of prostate cancer by regulating with miR-5590-3p/YY1 axis. Luo ZF; Peng Y; Liu FH; Ma JS; Hu G; Lai SL; Lin H; Chen JJ; Zou GM; Yan Q; Sui WG Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4697-4709. PubMed ID: 32432733 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1. Li X; Han X; Wei P; Yang J; Sun J Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062 [TBL] [Abstract][Full Text] [Related]
17. LncRNA CCAT1 promotes prostate cancer cells proliferation, migration, and invasion through regulation of miR-490-3p/FRAT1 axis. Cai X; Dai Y; Gao P; Ren G; Cheng D; Wang B; Wang Y; Yu J; Du Y; Wang X; Xue B Aging (Albany NY); 2021 Jul; 13(14):18527-18544. PubMed ID: 34319909 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA long intergenic non-coding 00641 mediates cell progression with stimulating cisplatin-resistance in osteosarcoma cells via microRNA-320d/myeloid cell leukemia-1 axis. Tang J; Zhu Z; Dong S; Wang Y; Wang J; Chen H; Duan G Bioengineered; 2022 Mar; 13(3):7238-7252. PubMed ID: 35266447 [TBL] [Abstract][Full Text] [Related]
19. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis. Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634 [TBL] [Abstract][Full Text] [Related]
20. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma. Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]